BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schmitt A, Rujescu D, Gawlik M, Hasan A, Hashimoto K, Iceta S, Jarema M, Kambeitz J, Kasper S, Keeser D, Kornhuber J, Koutsouleris N, Lanzenberger R, Malchow B, Saoud M, Spies M, Stöber G, Thibaut F, Riederer P, Falkai P; WFSBP Task Force on Biological Markers. Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics. World J Biol Psychiatry 2016;17:406-28. [PMID: 27311987 DOI: 10.1080/15622975.2016.1183043] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Jaskiw GE, Obrenovich ME, Donskey CJ. The phenolic interactome and gut microbiota: opportunities and challenges in developing applications for schizophrenia and autism. Psychopharmacology (Berl) 2019;236:1471-89. [PMID: 31197432 DOI: 10.1007/s00213-019-05267-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kranz GS, Kasper S. On the suitability of medical analogies, from hypertension to broken leg. The World Journal of Biological Psychiatry 2019;20:171-2. [DOI: 10.1080/15622975.2019.1585947] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Nunes A, Schnack HG, Ching CRK, Agartz I, Akudjedu TN, Alda M, Alnæs D, Alonso-Lana S, Bauer J, Baune BT, Bøen E, Bonnin CDM, Busatto GF, Canales-Rodríguez EJ, Cannon DM, Caseras X, Chaim-Avancini TM, Dannlowski U, Díaz-Zuluaga AM, Dietsche B, Doan NT, Duchesnay E, Elvsåshagen T, Emden D, Eyler LT, Fatjó-Vilas M, Favre P, Foley SF, Fullerton JM, Glahn DC, Goikolea JM, Grotegerd D, Hahn T, Henry C, Hibar DP, Houenou J, Howells FM, Jahanshad N, Kaufmann T, Kenney J, Kircher TTJ, Krug A, Lagerberg TV, Lenroot RK, López-Jaramillo C, Machado-Vieira R, Malt UF, McDonald C, Mitchell PB, Mwangi B, Nabulsi L, Opel N, Overs BJ, Pineda-Zapata JA, Pomarol-Clotet E, Redlich R, Roberts G, Rosa PG, Salvador R, Satterthwaite TD, Soares JC, Stein DJ, Temmingh HS, Trappenberg T, Uhlmann A, van Haren NEM, Vieta E, Westlye LT, Wolf DH, Yüksel D, Zanetti MV, Andreassen OA, Thompson PM, Hajek T; ENIGMA Bipolar Disorders Working Group. Using structural MRI to identify bipolar disorders - 13 site machine learning study in 3020 individuals from the ENIGMA Bipolar Disorders Working Group. Mol Psychiatry 2020;25:2130-43. [PMID: 30171211 DOI: 10.1038/s41380-018-0228-9] [Cited by in Crossref: 55] [Cited by in F6Publishing: 36] [Article Influence: 13.8] [Reference Citation Analysis]
4 Mascheretti S, De Luca A, Trezzi V, Peruzzo D, Nordio A, Marino C, Arrigoni F. Neurogenetics of developmental dyslexia: from genes to behavior through brain neuroimaging and cognitive and sensorial mechanisms. Transl Psychiatry 2017;7:e987. [PMID: 28045463 DOI: 10.1038/tp.2016.240] [Cited by in Crossref: 63] [Cited by in F6Publishing: 49] [Article Influence: 12.6] [Reference Citation Analysis]
5 Schmitt A, Martins-de-souza D, Akbarian S, Cassoli JS, Ehrenreich H, Fischer A, Fonteh A, Gattaz WF, Gawlik M, Gerlach M, Grünblatt E, Halene T, Hasan A, Hashimoto K, Kim Y, Kirchner S, Kornhuber J, Kraus TF, Malchow B, Nascimento JM, Rossner M, Schwarz M, Steiner J, Talib L, Thibaut F, Riederer P, Falkai P; The Members of the WFSBP Task Force on Biological Markers. Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms. The World Journal of Biological Psychiatry 2017;18:330-56. [DOI: 10.1080/15622975.2016.1224929] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
6 Dondé C, Luck D, Grot S, Leitman DI, Brunelin J, Haesebaert F. Tone-matching ability in patients with schizophrenia: A systematic review and meta-analysis. Schizophr Res 2017;181:94-9. [PMID: 27742161 DOI: 10.1016/j.schres.2016.10.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
7 Li M, Li X, Das TK, Deng W, Li Y, Zhao L, Ma X, Wang Y, Yu H, Meng Y, Wang Q, Palaniyappan L, Li T. Prognostic Utility of Multivariate Morphometry in Schizophrenia. Front Psychiatry 2019;10:245. [PMID: 31037060 DOI: 10.3389/fpsyt.2019.00245] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
8 Kurtulmus A, Elbay A, Parlakkaya FB, Kilicarslan T, Ozdemir MH, Kirpinar I. An investigation of retinal layer thicknesses in unaffected first-degree relatives of schizophrenia patients. Schizophr Res 2020;218:255-61. [PMID: 31948898 DOI: 10.1016/j.schres.2019.12.034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
9 Arslan A. Mapping the Schizophrenia Genes by Neuroimaging: The Opportunities and the Challenges. Int J Mol Sci 2018;19:E219. [PMID: 29324666 DOI: 10.3390/ijms19010219] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Goldsmith DR, Crooks CL, Walker EF, Cotes RO. An Update on Promising Biomarkers in Schizophrenia. Focus (Am Psychiatr Publ) 2018;16:153-63. [PMID: 31975910 DOI: 10.1176/appi.focus.20170046] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Trovão N, Prata J, VonDoellinger O, Santos S, Barbosa M, Coelho R. Peripheral Biomarkers for First-Episode Psychosis-Opportunities from the Neuroinflammatory Hypothesis of Schizophrenia. Psychiatry Investig 2019;16:177-84. [PMID: 30836740 DOI: 10.30773/pi.2018.12.19.1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
12 Patel S, Sharma D, Uniyal A, Akhilesh, Gadepalli A, Tiwari V. Recent advancements in biomarker research in schizophrenia: mapping the road from bench to bedside. Metab Brain Dis 2022. [PMID: 35239143 DOI: 10.1007/s11011-022-00926-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Bryll A, Krzyściak W, Karcz P, Pilecki M, Śmierciak N, Szwajca M, Skalniak A, Popiela TJ. Determinants of Schizophrenia Endophenotypes Based on Neuroimaging and Biochemical Parameters. Biomedicines 2021;9:372. [PMID: 33916324 DOI: 10.3390/biomedicines9040372] [Reference Citation Analysis]
14 Postolache TT, Del Bosque-Plata L, Jabbour S, Vergare M, Wu R, Gragnoli C. Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome. Am J Med Genet B Neuropsychiatr Genet 2019;180:186-203. [PMID: 30729689 DOI: 10.1002/ajmg.b.32712] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 14.0] [Reference Citation Analysis]
15 Hosak L, Sery O, Sadykov E, Studnicka J. Retinal abnormatilites as a diagnostic or prognostic marker of schizophrenia. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2018;162:159-64. [DOI: 10.5507/bp.2018.035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Giegling I, Hosak L, Mössner R, Serretti A, Bellivier F, Claes S, Collier DA, Corrales A, Delisi LE, Gallo C, Gill M, Kennedy JL, Leboyer M, Maier W, Marquez M, Massat I, Mors O, Muglia P, Nöthen MM, Ospina-duque J, Owen MJ, Propping P, Shi Y, St Clair D, Thibaut F, Cichon S, Mendlewicz J, O'donovan MC, Rujescu D. Genetics of schizophrenia: A consensus paper of the WFSBP Task Force on Genetics. The World Journal of Biological Psychiatry 2017;18:492-505. [DOI: 10.1080/15622975.2016.1268715] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 7.2] [Reference Citation Analysis]
17 Lange C, Deutschenbaur L, Borgwardt S, Lang UE, Walter M, Huber CG. Experimentally induced psychosocial stress in schizophrenia spectrum disorders: A systematic review. Schizophrenia Research 2017;182:4-12. [DOI: 10.1016/j.schres.2016.10.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
18 Peter F, Andrea S, Nancy A. Forty years of structural brain imaging in mental disorders: is it clinically useful or not? Dialogues Clin Neurosci 2018;20:179-86. [PMID: 30581287 [PMID: 30581287 DOI: 10.31887/dcns.2018.20.3/pfalkai] [Cited by in Crossref: 12] [Article Influence: 4.0] [Reference Citation Analysis]
19 Arslan A. Imaging genetics of schizophrenia in the post-GWAS era. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2018;80:155-65. [DOI: 10.1016/j.pnpbp.2017.06.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
20 Levchenko A, Nurgaliev T, Kanapin A, Samsonova A, Gainetdinov RR. Current challenges and possible future developments in personalized psychiatry with an emphasis on psychotic disorders. Heliyon 2020;6:e03990. [PMID: 32462093 DOI: 10.1016/j.heliyon.2020.e03990] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Plummer JT, Gordon AJ, Levitt P. The Genetic Intersection of Neurodevelopmental Disorders and Shared Medical Comorbidities - Relations that Translate from Bench to Bedside. Front Psychiatry 2016;7:142. [PMID: 27597832 DOI: 10.3389/fpsyt.2016.00142] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
22 Mascheretti S, De Luca A, Trezzi V, Peruzzo D, Nordio A, Marino C, Arrigoni F. Neurogenetics of developmental dyslexia: from genes to behavior through brain neuroimaging and cognitive and sensorial mechanisms. Transl Psychiatry 2017;7:e987. [PMID: 28045463 DOI: 10.1038/tp.2016.240] [Cited by in F6Publishing: 1] [Reference Citation Analysis]